Compared to Semaglutide and Tirzepatide, retatrutide's special inclusion of glucagon receptor agonism together with GIP and GLP-1 receptor agonism offers a definite pharmacological profile. Whilst Semaglutide is often a GLP-1 receptor agonist and Tirzepatide brings together GLP-1 and GIP receptor agonism, retatrutide's triple mechanism could potentially give broader metabolic Advantages. https://corepepptides.com/product/retatrutide-injection-pen/